CBZ vs RTX

CBZ presents a complex profile with a stable but mediocre Piotroski F-Score of 4/9 and a missing Altman Z-Score, indicating a lack of strong financial momentum. While the stock appears undervalued based on the Graham Number ($36.84) and a Price-to-Book ratio of 0.93, it trades significantly above its growth-based intrinsic value ($12.81). Strong revenue growth (17.9%) is currently offset by a concerning negative operating margin (-7.37%) and a severe 1-year price decline of 53.8%. The disconnect between analyst 'Buy' ratings and bearish insider activity suggests a high-risk value play.

RTX exhibits stable financial health with a Piotroski F-Score of 5/9, yet it is trading at a severe premium compared to its Graham Number ($73.73) and Intrinsic Value ($96.67). While the company boasts an exceptional track record of earnings beats over 25 quarters and solid revenue growth, the valuation is stretched with a PEG ratio of 2.75. This fundamental overvaluation is compounded by bearish insider sentiment and a weak technical trend, suggesting that while the business is strong, the stock price is currently decoupled from its deterministic value.